Decoding the role of the nuclear receptor SHP in regulating hepatic stellate cells and liver fibrogenesis
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
The small heterodimer partner (SHP) is an orphan nuclear receptor that lacks the DNA binding domain while conserves a putative ligand-binding site, thought that endogenous ligands for this receptor are unknown. Previous studies have determined that SHP activation protects against development of liver fibrosis a process driven by trans-differentiation and activation of hepatic stellate cells (HSCs), a miofibroblast like cell type, involved in extracellular matrix (ECM) deposition. To dissect signals involved in this activity we generated SHP-overexpressing human and rat HSCs. Forced expression of SHP in HSC-T6 altered the expression of 574 genes. By pathway and functional enrichment analyses we detected a cluster of 46 differentially expressed genes involved in HSCs trans-differentiation. Using a isoxazole scaffold we designed and synthesized a series of SHP agonists. The most potent member of this group, ISO-COOH (EC 50: 9 μM), attenuated HSCs trans-differentiation and ECM deposition in vitro, while in mice rendered cirrhotic by carbon tetrachloride (CCl 4) or α-naphthyl-isothiocyanate (ANIT), protected against development of liver fibrosis as measured by morphometric analysis and expression of α-SMA and α1-collagen mRNAs. In aggregate, present results identify SHP as a counter-regulatory signal for HSCs transactivation and describe a novel class of SHP agonists endowed with anti-fibrotic activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The anti-fibrotic role of SHP was additionally confirmed in SHPoverexpressing LX2-HSCs by its counter-regulatory signal for HSCs transactivation, which prompted further studies on SHP signaling and identification of so far unknown SHP agonists.[64,65]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [65]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
KOBAS 2.0: a web server for annotation and identification of enriched pathways and diseases
Xie, C., Mao, X., Huang, J., Ding, Y., Wu, J., Dong, S., Kong, L., Gao, G., Li, C.-Y., & Wei, L. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr483 · Cited by 5,094
Nuclear Receptors, RXR, and the Big Bang
Evans, R. M., & Mangelsdorf, D. J. (2014) · Cell · doi:10.1016/j.cell.2014.03.012 · Cited by 1,200
Seol, W., Choi, H.-S., & Moore, D. D. (1996) · Science · doi:10.1126/science.272.5266.1336 · Cited by 534
Identification of a Chemical Tool for the Orphan Nuclear Receptor FXR
Maloney, P. R., Parks, D. J., Haffner, C. D., Fivush, A. M., Chandra, G., Plunket, K. D., Creech, K. L., Moore, L. B., Wilson, J. G., Lewis, M. C., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm0002127 · Cited by 527
Fiorucci, S., Antonelli, E., Rizzo, G., Renga, B., Mencarelli, A., Riccardi, L., Orlandi, S., Pellicciari, R., & Morelli, A. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.08.001 · Cited by 472
Self-citationThe role of TGFβ1 in initiating hepatic stellate cell activation in vivo
Hellerbrand, C., Stefanovic, B., Giordano, F., Burchardt, E. R., & Brenner, D. A. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80010-5 · Cited by 393
Dooley, S., Delvoux, B., Streckert, M., Bonzel, L., Stopa, M., ten Dijke, P., & Gressner, A. M. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02656-4 · Cited by 196
Fiorucci, S., Clerici, C., Antonelli, E., Orlandi, S., Goodwin, B., Sadeghpour, B. M., Sabatino, G., Russo, G., Castellani, D., Willson, T. M., et al. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.079665 · Cited by 196
Self-citationGeneral Molecular Biology and Architecture of Nuclear Receptors
Pawlak, M., Lefebvre, P., & Staels, B. (2012) · Current Topics in Medicinal Chemistry · doi:10.2174/156802612799436641 · Cited by 167
Sanyal, S., Kim, J.-Y., Kim, H.-J., Takeda, J., Lee, Y.-K., Moore, D. D., & Choi, H.-S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106140200 · Cited by 155
Cited by
Thompson, M. D., Moghe, A., Cornuet, P. K., Marino, R. B., Tian, J., Wang, P., Ma, X., Abrams, M. T., Locker, J. D., Monga, S. P., et al. (2017) · Hepatology · doi:10.1002/hep.29371 · Cited by 68
Nuclear Receptors as Multiple Regulators of NLRP3 Inflammasome Function
Alatshan, A., & Benkő, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.630569 · Cited by 60
Linking liver metabolic and vascular disease via bile acid signaling
Fiorucci, S., & Distrutti, E. (2021) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2021.10.005 · Cited by 49
Self-citationObeticholic Acid and Other Farnesoid-X-Receptor (FXR) Agonists in the Treatment of Liver Disorders
Fiorucci, S., Urbani, G., Distrutti, E., & Biagioli, M. (2025) · Pharmaceuticals · doi:10.3390/ph18091424 · Cited by 47
Self-citationNuclear receptors in liver fibrosis
Königshofer, P., Brusilovskaya, K., Petrenko, O., Hofer, B. S., Schwabl, P., Trauner, M., & Reiberger, T. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166235 · Cited by 45
Carino, A., Biagioli, M., Marchianò, S., Scarpelli, P., Zampella, A., Limongelli, V., & Fiorucci, S. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.02.033 · Cited by 44
Self-citationMagee, N. S., Zou, A., Ghosh, P., Ahamed, F., Delker, D. A., & Zhang, Y. (2020) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)49910-8 · Cited by 28
Magee, N. S., Zou, A., Ghosh, P., Ahamed, F., Delker, D. A., & Zhang, Y. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010233 · Cited by 18
Rapacciuolo, P., Finamore, C., Giorgio, C. D., Fiorillo, B., Massa, C., Urbani, G., Marchianò, S., Bordoni, M., Cassiano, C., Morretta, E., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c01651 · Cited by 17
Self-citationLong non coding RNA H19: An emerging therapeutic target in fibrosing diseases
Li, J., Cao, L., Liu, H., Yin, X., & Wang, J. (2019) · Autoimmunity · doi:10.1080/08916934.2019.1681983 · Cited by 17
Roles of nuclear receptors in hepatic stellate cells
Pu, S., Zhou, H., Liu, Y., Liu, J., Guo, Y., & Zhou, H. (2021) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2021.1949288 · Cited by 13
Shaw, R. P. H., Kolyvas, P. G., Dang, N., Hyon, A., Bailey, K., & Anakk, S. (2022) · Endocrinology · doi:10.1210/endocr/bqac052 · Cited by 10
The long and the small collide: LncRNAs and small heterodimer partner (SHP) in liver disease
Wu, J., Nagy, L. E., & Wang, L. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111262 · Cited by 9
Shaw, R. P. H., Kolyvas, P. G., Dang, N., Hyon, A., & Anakk, S. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.07.459308
Shaw, R. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.17632/zb6mmp3zm3
Wu, Q., Gao, L.-Y., Feng, H., Liu, H.-L., Gao, H., Peng, W., & Li, N. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1797381
Metadata
- Authors
- Cipriani, S., Carino, A., Masullo, D., Zampella, A., Distrutti, E., & Fiorucci, S.
- Affiliations
- University of Perugia (IT)
- University of Naples Federico II (IT)
- Azienda Ospedaliera di Perugia (IT)
- Corresponding author
- Fiorucci, Stefano
- Venue
- Scientific Reports
- Published
- 2017-01-24
- Volume
- 7
- Issue
- 1
- Pages
- 41055-41055
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC5259793
- OpenAlex
- W2582978808
- Cited by
- 16
- References
- 29
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 1 · 2022: 1 · 2021: 6 · 2020: 1 · 2019: 2 · 2018: 1 · 2017: 1
- FWCI
- 0.84
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- small heterodimer partner, SHP, orphan nuclear receptor, hepatic stellate cells, liver fibrosis, transdifferentiation, extracellular matrix deposition, antifibrotic activity, carbon tetrachloride-induced cirrhosis, alpha-naphthylisothiocyanate, alpha-smooth muscle actin, type I collagen
- MeSH terms
- Animals, Carbon Tetrachloride, Disease Models, Animal, Extracellular Matrix, Gene Expression Regulation, Humans, Liver Cirrhosis, Male, 1-Naphthylisothiocyanate, Receptors, Cytoplasmic and Nuclear, Gene Expression Profiling, Mice, Rats, Hepatic Stellate Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.